
27 Jul 4DMT
Anthony Baldor, Vice President, Corporate Strategy & Business Development
Oct. 12 | 11:30am | AVROBIO Ballroom
Emeryville, CA
(NASDAQ: FDMT)
In-person Presentation
4DMT is a gene therapy company with a transformative discovery platform – Therapeutic Vector Evolution – that enables our “disease first” approach to product discovery and development, thereby allowing us to customize our AAV vectors to target specific tissue types associated with the underlying disease.